Event Brief
Apr 30, 2026 at 6:05 PM ET
FDA moves to exclude weight loss drugs from 503B list
By The BriefBrief
The FDA moved to exclude semaglutide, tirzepatide and liraglutide from its 503B bulks list.
WHO: The FDA
WHAT: Excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list
WHEN: Apr 30, 2026 at 4:55 PM ET
WHERE: Location not specified
WHY: No specific cause was reported.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21472 of 21472
Same format. Every time.
Continue reading — sign in or create a free account with
